Qube Research & Technologies (QRT)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,600
Closed -$212K 3652
2024
Q4
$212K Hold
1,600
﹤0.01% 2825
2024
Q3
$233K Hold
1,600
﹤0.01% 2524
2024
Q2
$220K Sell
1,600
-600
-27% -$80.1K ﹤0.01% 2398
2024
Q1
$302K Buy
+2,200
New +$300K ﹤0.01% 2810

Other funds holding IBB

Qube Research & Technologies (QRT)'s IBB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its iShares Biotechnology ETF (IBB) stake by 576% in Q2 2026, buying an estimated $6.92M and bringing the position to 47,278 shares worth $8.99M. The position accounts for 0.01% of the portfolio, ranked #1345.

Qube Research & Technologies (QRT) first reported a position in IBB in Q2 2020 and has held it in 16 quarters since. The position peaked at $63.7M in Q3 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 47,278 shares of iShares Biotechnology ETF worth $8.99M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 40,281 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.92M.
  • iShares Biotechnology ETF made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1345 holding.
  • Qube Research & Technologies (QRT) first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 16 quarters since.
  • Qube Research & Technologies (QRT)'s iShares Biotechnology ETF position peaked at $63.7M in Q3 2021.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.